Dialysis Membranes and Hemodynamic Tolerance
Launched by OSPEDALE REGIONALE DI LOCARNO · Jul 9, 2013
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 18 and older
- • ability to understand the information presented and sign the informed consent
- • chronic hemodialysis for at least 8 weeks
- • stable dialysis prescriptions and modality in the 2 weeks prior to protocol implementation
- Exclusion Criteria:
- • mental illness;
- • inability to understand the information presented and sign the informed consent;
- • acute disease requiring hospitalization at the time of patient enrolment
- • pregnancy and breast feeding
About Ospedale Regionale Di Locarno
Ospedale Regionale di Locarno is a leading healthcare institution in Switzerland, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a focus on multidisciplinary collaboration, the hospital leverages its state-of-the-art facilities and a team of experienced professionals to conduct a wide range of clinical studies. Ospedale Regionale di Locarno actively engages in research initiatives that address critical health challenges, ensuring adherence to the highest ethical standards and regulatory compliance, thereby contributing to the global advancement of medical knowledge and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Locarno, Ticino, Switzerland
Patients applied
Trial Officials
Luca Gabutti, MD
Principal Investigator
Ospedale Regionale Locarno
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials